Business Context and Reporting Period
Company: Aeluma, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 20, 2026
Reporting Period: Event date March 20, 2026
Business Context: Aeluma, Inc., an emerging growth company incorporated in Delaware, entered into a material definitive agreement to establish an at-the-market equity offering program.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on the authorization of a potential equity offering.
- Maximum Offering Size: Up to $50.0 million in aggregate sales price of common stock.
- Trading Symbol: ALMU (Nasdaq Capital Market).
- Registration Basis: Shelf registration statement on Form S-3 (Registration No. 333-289135), declared effective August 8, 2025.
Material Changes
The primary material change reported is the execution of a Sales Agreement with Roth Capital Partners, LLC (as representative), Craig-Hallum Capital Group LLC, Northland Securities, Inc., and The Benchmark Company, LLC (collectively, the "Agents").
- Agreement Terms: The Company may sell shares from time to time through the Agents via ordinary brokers' transactions at market prices.
- Obligations: Neither the Company nor the Agents are obligated to sell or purchase any shares. No assurance is given regarding the price, number of shares, or timing of sales.
- Termination: Either party may terminate the agreement upon 5 business days' prior written notice.
- Indemnification: The Company agreed to indemnify the Agents against certain liabilities under the Securities Act of 1933 and the Securities Exchange Act of 1934.
Guidance, Outlook, and Risks
Management Commentary: The filing indicates the Company has established a mechanism to raise capital but explicitly states there is no obligation to utilize it. The filing does not provide specific guidance on future capital needs or operational outlook beyond the establishment of this facility.
Risks and Contingencies:
- Uncertainty of Execution: There is no guarantee that any shares will be sold under the agreement.
- Market Price Volatility: Sales will be made at prevailing market prices, which may fluctuate.
- Dilution: Issuance of shares under this agreement will result in dilution to existing shareholders, though the extent depends on future sales.
Investor Verification Checklist
- Verify the current share price and market capitalization to assess the potential dilution impact of a full $50.0 million offering.
- Review the Company's most recent 10-K or 10-Q to understand current cash reserves and the immediate necessity of this capital raise.
- Examine the full text of the Sales Agreement (Exhibit 1.1) for specific commission rates and indemnification caps not detailed in the summary.
- Confirm the status of the underlying Form S-3 shelf registration (No. 333-289135) to ensure no subsequent amendments or withdrawals have occurred.